Views & Analysis Do patients want injectable therapy for dry eyes? How can sophisticated market research help make innovative injectable therapy more appealing to patients with dry eye syndrome?
News Mixed data mar Sanofi's venglustat programme Sanofi has reported positive phase 3 results with venglustat in Gauder disease, but the drug missed the mark in a Fabry disease trial.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.